Unveiling the Anticancer Mechanisms of Isorhamnetin: A Mini Review
Journal of Medicinal Chemistry and Therapeutics · 2025
DOI: 10.71193/jmct.20250002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry and Therapeutics, 2025. Verfasst von Md Anisur Rahman und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Isorhamnetin (ISO), a flavonoid, exhibits significant anticancer properties; however, no review has been conducted on its anticancer activity. This mini-review evaluates the anticancer potential of ISO by summarizing its mechanisms of action based on studies from PubMed, Google Scholar, ScienceDirect and Web of Science. Research on breast, colon, lung, colorectal, gastric, prostate, skin, and gallbladder models, both in vitro and in vivo, supports ISO's anticancer properties. This review highlights its mechanisms of function, including cell cycle arrest, apoptosis induction, and inhibition of key oncogenic pathways such as mitogen-activated protein kinase (MAPK), epithelial-mesenchymal transition (EMT) and phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR). ISO also enhances reactive oxygen species (ROS) production, modulates mitochondrial pathways, and reduces metastasis by inhibiting matrix metalloproteinases (MMPs). Further research is needed on ISO’s pharmacokinetics and clinical efficacy to establish this as an anticancer agent.
Zitieren
APA
Rahman, M. A., Shipon, M. N. H., Akter, M. S., Sakib, M. N., Uddin, M. F., Rahman, T., & Hasan, M. S. A. (2025). Unveiling the Anticancer Mechanisms of Isorhamnetin: A Mini Review. Journal of Medicinal Chemistry and Therapeutics. https://doi.org/10.71193/jmct.20250002
Vancouver
Rahman MA, Shipon MNH, Akter MS, Sakib MN, Uddin MF, Rahman T, et al. Unveiling the Anticancer Mechanisms of Isorhamnetin: A Mini Review. Journal of Medicinal Chemistry and Therapeutics. 2025. doi:10.71193/jmct.20250002
BibTeX
@article{Rahman2025,
author = {Rahman, Md Anisur and Shipon, Md. Nasimul Haque and Akter, Mst. Sumaia and Sakib, Md. Nazmus and Uddin, Md. Farid and Rahman, Taposy and Hasan, Md. Sakib Al},
title = {Unveiling the Anticancer Mechanisms of Isorhamnetin: A Mini Review},
journal = {Journal of Medicinal Chemistry and Therapeutics},
year = {2025},
doi = {10.71193/jmct.20250002}
}
EUVIMED